Leili Rahimi

513 total citations
17 papers, 340 citations indexed

About

Leili Rahimi is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Leili Rahimi has authored 17 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Surgery and 4 papers in Epidemiology. Recurrent topics in Leili Rahimi's work include Adrenal and Paraganglionic Tumors (5 papers), Hormonal Regulation and Hypertension (5 papers) and Pituitary Gland Disorders and Treatments (4 papers). Leili Rahimi is often cited by papers focused on Adrenal and Paraganglionic Tumors (5 papers), Hormonal Regulation and Hypertension (5 papers) and Pituitary Gland Disorders and Treatments (4 papers). Leili Rahimi collaborates with scholars based in United States, Iran and Australia. Leili Rahimi's co-authors include Faramarz Ismail‐Beigi, Aman Rajpal, Jinhong Sun, Mohammad Hossein Razi Jalali, Huan Guo, Seyed Reza Fatemi Tabatabaei, Peter Arvan, Ming Liu, Nischay Rege and Mohammad E. Khamseh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Leili Rahimi

15 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leili Rahimi United States 8 125 87 86 85 64 17 340
Aman Rajpal United States 9 144 1.2× 82 0.9× 80 0.9× 72 0.8× 53 0.8× 20 390
Cem Haymana Türkiye 12 213 1.7× 76 0.9× 72 0.8× 74 0.9× 77 1.2× 45 433
Matthias Hepprich Switzerland 9 82 0.7× 114 1.3× 48 0.6× 72 0.8× 53 0.8× 25 326
Kai Yan Mak Australia 8 94 0.8× 36 0.4× 149 1.7× 44 0.5× 66 1.0× 9 338
А. В. Охлобыстин Russia 9 28 0.2× 38 0.4× 68 0.8× 118 1.4× 48 0.8× 23 274
J Osztovits Hungary 9 55 0.4× 24 0.3× 115 1.3× 42 0.5× 46 0.7× 23 338
José Silva‐Nunes Portugal 11 122 1.0× 23 0.3× 62 0.7× 63 0.7× 43 0.7× 48 274
Wirawan Adikusuma Indonesia 10 37 0.3× 65 0.7× 37 0.4× 20 0.2× 83 1.3× 64 296
Cèlia Rodríguez-Borjabad Spain 9 99 0.8× 62 0.7× 59 0.7× 180 2.1× 53 0.8× 21 359
Julia Guerrero Chile 12 98 0.8× 41 0.5× 127 1.5× 28 0.3× 64 1.0× 24 401

Countries citing papers authored by Leili Rahimi

Since Specialization
Citations

This map shows the geographic impact of Leili Rahimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leili Rahimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leili Rahimi more than expected).

Fields of papers citing papers by Leili Rahimi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leili Rahimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leili Rahimi. The network helps show where Leili Rahimi may publish in the future.

Co-authorship network of co-authors of Leili Rahimi

This figure shows the co-authorship network connecting the top 25 collaborators of Leili Rahimi. A scholar is included among the top collaborators of Leili Rahimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leili Rahimi. Leili Rahimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Hamidi, Oksana, Prerna Dogra, Shobana Athimulam, et al.. (2025). Bilateral Adrenal Nodules Presenting With Mild Autonomous Cortisol Secretion. Endocrine Practice. 31(8). 1071–1083.
3.
Rahimi, Leili, Fan Feng, Nicole A. Becker, et al.. (2025). Approaches to reduce succinate accumulation by restoration of succinate dehydrogenase activity in cultured adrenal cells. Journal of Cell Science. 138(9).
4.
Dogra, Prerna, et al.. (2024). Adrenal Hemorrhage: A Comprehensive Analysis of a Heterogeneous Entity—Etiology, Presentation, Management, and Outcomes. Mayo Clinic Proceedings. 99(3). 375–386. 3 indexed citations
5.
Rahimi, Leili, Prerna Dogra, Elizabeth J. Atkinson, et al.. (2023). Kidney Function in Patients With Adrenal Adenomas: A Single-Center Retrospective Cohort Study. The Journal of Clinical Endocrinology & Metabolism. 109(9). e1750–e1758. 4 indexed citations
6.
Dogra, Prerna, et al.. (2023). Etiology, morphology, and outcomes of adrenal calcifications in 540 adult patients—a retrospective single-center study. European Journal of Endocrinology. 189(1). K1–K6. 2 indexed citations
7.
Rahimi, Leili & Juan P. Brito. (2022). U.S. Thyroid Cancer Incidence Fell but Mortality Climbing in Recent Years. Clinical Thyroidology. 34(5). 213–215. 2 indexed citations
8.
Rege, Nischay, Ming Liu, Yanwu Yang, et al.. (2020). Evolution of insulin at the edge of foldability and its medical implications. Proceedings of the National Academy of Sciences. 117(47). 29618–29628. 26 indexed citations
9.
Rahimi, Leili, Mojtaba Malek, Faramarz Ismail‐Beigi, & Mohammad E. Khamseh. (2020). Challenging Issues in the Management of Cardiovascular Risk Factors in Diabetes During the COVID-19 Pandemic: A Review of Current Literature. Advances in Therapy. 37(8). 3450–3462. 7 indexed citations
10.
Rege, Nischay, Ming Liu, Balamurugan Dhayalan, et al.. (2020). “Register-shift” insulin analogs uncover constraints of proteotoxicity in protein evolution. Journal of Biological Chemistry. 295(10). 3080–3098. 10 indexed citations
11.
Rahimi, Leili, Aman Rajpal, & Faramarz Ismail‐Beigi. (2020). <p>Glucocorticoid-Induced Fatty Liver Disease</p>. Diabetes Metabolic Syndrome and Obesity. Volume 13. 1133–1145. 94 indexed citations
12.
Rajpal, Aman, Leili Rahimi, & Faramarz Ismail‐Beigi. (2020). Factors leading to high morbidity and mortality of COVID‐19 in patients with type 2 diabetes. Journal of Diabetes. 12(12). 895–908. 118 indexed citations
13.
Rahimi, Leili, et al.. (2019). <p>SGLT-2 inhibitors as promising therapeutics for non-alcoholic fatty liver disease: pathophysiology, clinical outcomes, and future directions</p>. Diabetes Metabolic Syndrome and Obesity. Volume 12. 1001–1012. 23 indexed citations
14.
Rahimi, Leili, et al.. (2019). Disturbances in Insulin–Glucose Metabolism in Patients With Advanced Renal Disease With and Without Diabetes. The Journal of Clinical Endocrinology & Metabolism. 104(11). 4949–4966. 32 indexed citations
15.
Shakeri, Mohammad Taghi, et al.. (2017). Pitfalls in Estimation of Celiac Disease Prevalence Using Serology: A Cross-Sectional Study. GOVARESH. 21(4). 266–271. 1 indexed citations
16.
Ganji, Azita, et al.. (2016). Correlation Between Cut-off Level of Tissue Transglutaminase Antibody and Marsh Classification. Middle East Journal of Digestive Diseases. 8(4). 318–322. 10 indexed citations
17.
Tabatabaei, Seyed Reza Fatemi, et al.. (2008). The Effects of Oral Vitamin E on Induction and Consequence of Experimental Diabetes Mellitus in Rats. Pakistan Journal of Biological Sciences. 11(4). 633–637. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026